| 1 |
Tunçel A, Yurt F. Chemo-Photothermal Combination Therapy of HER-2 Overexpressing Breast Cancer Cells with Dual-Ordered Mesoporous Carbon@Silica Nanocomposite. Appl Biochem Biotechnol 2023;195:1904-27. [PMID: 36401724 DOI: 10.1007/s12010-022-04235-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Thummarati P, Suksiriworapong J, Sakchaisri K, Nawroth T, Langguth P, Roongsawang B, Junyaprasert VB. Comparative study of dual delivery of gemcitabine and curcumin using CD44 targeting hyaluronic acid nanoparticles for cancer therapy. Journal of Drug Delivery Science and Technology 2022;77:103883. [DOI: 10.1016/j.jddst.2022.103883] [Reference Citation Analysis]
|
| 3 |
Qiu Q, Lu D, Liu G, Yang X, Li J, Ren H, Liu J, Sun B, Zhang Y. Colistin Crosslinked Gemcitabine Micelles to Eliminate Tumor Drug Resistance Caused by Intratumoral Microorganisms. Bioconjug Chem 2022. [PMID: 36191256 DOI: 10.1021/acs.bioconjchem.2c00407] [Reference Citation Analysis]
|
| 4 |
Wang Y, Qiu Q, Liao R, Wang X, Zhou Z, Zhang X, Zhang H, He Z, Zhang S, Luo C, Sun J. Modularly engineered prodrug-nanoassemblies for cancer therapy: Nonpharmacological moiety dominating delivery fates. Nano Res . [DOI: 10.1007/s12274-022-4819-z] [Reference Citation Analysis]
|
| 5 |
Very N, El Yazidi-belkoura I. Targeting O-GlcNAcylation to overcome resistance to anti-cancer therapies. Front Oncol 2022;12:960312. [DOI: 10.3389/fonc.2022.960312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Karabatak A, Danışman-kalındemirtaş F, Tan E, Erdem-kuruca S, Karakuş S. Kappa carrageenan/PEG-CuO nanoparticles as a multifunctional nanoplatform: digital colorimetric biosensor and anticancer drug nanocarrier. Appl Phys A 2022;128. [DOI: 10.1007/s00339-022-05802-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Chen X, Jia F, Huang Y, Jin Q, Ji J. Cancer-Associated Fibroblast-Targeted Delivery of Captopril to Overcome Penetration Obstacles for Enhanced Pancreatic Cancer Therapy. ACS Appl Bio Mater 2022. [PMID: 35786827 DOI: 10.1021/acsabm.2c00486] [Reference Citation Analysis]
|
